Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
epi/lidocai/tetracai topical 180 mg-4000 mg-500 mg/100 mL Sol [SFKS] (CDM 5749359_1) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 28, 2026 , from http://ppman.hank.ai/transparency/procedure/5749359_1/by-state?code_type=CDM
“epi/lidocai/tetracai topical 180 mg-4000 mg-500 mg/100 mL Sol [SFKS] (CDM 5749359_1) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/5749359_1/by-state?code_type=CDM. Accessed
October 28, 2026 .
“epi/lidocai/tetracai topical 180 mg-4000 mg-500 mg/100 mL Sol [SFKS] (CDM 5749359_1) by State,” HANK Price Transparency ,
accessed October 28, 2026 ,
http://ppman.hank.ai/transparency/procedure/5749359_1/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
5749359_1 — Epi/lidocai/tetracai Topical 180 Mg-4000 Mg-500 Mg/100 Ml Sol [sfks]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$14,594
National median
$14,594 – $14,594
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 5749359_1 (CDM), with interquartile range
State Median p25 p75
KS $14,594 $14,594 $14,594